PRESS RELEASE RE PRELIMINARY PHASE 2 CLINICAL TRIAL

Company

BioRestorative Therapies, Inc.

Filed

February 1, 2024

Period of Report

February 1, 2024

Accession Number

0001021771-24-000025

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →